Home
Forums
New posts
What's new
New posts
Latest activity
Members
Registered members
Current visitors
Log in
What's new
New posts
Menu
Log in
Install the app
Install
Home
Forums
Public Area
Timebomb2000
EPIDEMIC/PANDEMIC DISEASE ARCHIVES
Emergence of a New Creutzfeldt-Jakob Disease:26 Cases of the Human Version of Mad-Cow Disease, Days After a COVID-19 Injection
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Members who reacted to message #7
All
(9)
Like
(5)
Sad
(2)
Angry
(1)
OMG
(1)
Jan 20, 2023
wobble
Veteran Member
Messages
5,715
Reaction score
14,117
Points
194
Jan 18, 2023
vessie
Has No Life - Lives on TB
Messages
17,410
Reaction score
11,568
Points
194
Jan 18, 2023
JMG91
Veteran Member
·
Location:
Georgia
Messages
3,727
Reaction score
13,002
Points
144
W
Jan 18, 2023
willowlady
Veteran Member
·
Location:
Pacific NW
Messages
6,104
Reaction score
2,800
Points
194
Jan 18, 2023
TheSearcher
Are you sure about that?
·
Location:
Houston
Messages
27,720
Reaction score
39,356
Points
294
J
Jan 18, 2023
John Deere Girl
Veteran Member
Messages
7,510
Reaction score
28,915
Points
194
Jan 18, 2023
psychgirl
Has No Life - Lives on TB
Messages
19,436
Reaction score
55,048
Points
194
Jan 18, 2023
ioujc
MARANTHA!! Even so, come LORD JESUS!!!
·
Location:
"Far far away in never-never land"
Messages
8,014
Reaction score
16,714
Points
194
Jan 18, 2023
packyderms_wife
Neither here nor there.
·
Location:
Central Iowa
Messages
86,715
Reaction score
118,855
Points
294
Loading…
Loading…
Loading…
Loading…
Home
Forums
Public Area
Timebomb2000
EPIDEMIC/PANDEMIC DISEASE ARCHIVES
Emergence of a New Creutzfeldt-Jakob Disease:26 Cases of the Human Version of Mad-Cow Disease, Days After a COVID-19 Injection
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top